Abstract P6-18-17: Ribociclib + letrozole in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (aBC) with no prior endocrine therapy (ET) for ABC: CompLEEment-1 trial, preliminary results from Spanish population

J Salvador, EM Ciruelos,A Prat, B Jiménez-Rodríguez,L de la Cruz, N Martínez,R Villanueva Vázquez, R de Toro, A Antón, F Moreno, I Alvarez, J Gavila, V Quiroga, E Vicente,J de la Haba, S González-Santiago, N Díaz, A Barnadas, B Cantos Sánchez de Ibargüen, JI Delgado, M Bellet, A Gimeno, S Sanz,M Martin

Poster Session Abstracts（2019）

引用 0|浏览2

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要